Inventor · disambiguated record
Gregori J. Morriello
Also filed as: MORRIELLO GREGORI · MORRIELLO GREGORI J
26 granted patents·11 pending applications·545 citations·filing 1994–2023
96Inventor score
Files withMERCK & CO INC10MERCK SHARP & DOHME7MERCK SHARP & DOHME LLC5BERGER RICHARD4MORRIELLO GREGORI J4
Top patents by PatentIndex Score
37 records- 0195US8247415B2Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonistsBERGER RICHARD·Filed 2009·Granted Aug 21, 2012·40 cites·16 claims
- 0294US8399480B2Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonistsBERGER RICHARD·Filed 2009·Granted Mar 19, 2013·36 cites·20 claims
- 0391US8653260B2Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonistsBERGER RICHARD·Filed 2012·Granted Feb 18, 2014·18 cites·11 claims
- 0491US5721250ADi-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormoneMERCK & CO INC·Filed 1996·Granted Feb 24, 1998·86 cites·3 claims
- 0591US5492916ADi- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormoneMERCK & CO INC·Filed 1994·Granted Feb 20, 1996·96 cites·10 claims
- 0690US5494919A2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormoneMERCK & CO INC·Filed 1994·Granted Feb 27, 1996·104 cites·7 claims
- 0784US5622973ATreatment of osteoporosis with substituted piperidines, pyrrolidines and hexahydro-1H-azepines in combination with bisphosphonatesMERCK & CO INC·Filed 1995·Granted Apr 22, 1997·46 cites·26 claims
- 0879US5663171AAcyclic compounds promote release of growth hormoneMERCK & CO INC·Filed 1995·Granted Sep 2, 1997·45 cites·9 claims
- 0978US12030872B2N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 9, 2024·2 cites·15 claims
- 1078US6812234B2Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activityMERCK & CO INC·Filed 2003·Granted Nov 2, 2004·14 cites·29 claims
- 1176US9186354B2Pyrrolidine derived β3 adrenergic receptor agonistsMORRIELLO GREGORI J·Filed 2011·Granted Nov 17, 2015·5 cites·6 claims
- 1275US7230008B2Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activityMERCK & CO INC·Filed 2004·Granted Jun 12, 2007·5 cites·12 claims
- 1375US6121325ANaphthyl compounds promote release of growth hormoneMERCK & CO INC·Filed 1997·Granted Sep 19, 2000·33 cites·11 claims
- 1471US6387932B1Somatostatin agonistsMERCK & CO INC·Filed 2000·Granted May 14, 2002·7 cites·12 claims
- 1570US10138255B2Piperazine derivatives as HIV protease inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Nov 27, 2018·1 cites·19 claims
- 1670US9840478B2Piperazine derivatives as HIV protease inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Dec 12, 2017·1 cites·13 claims
- 1770US7786305B2Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activityMERCK SHARP & DOHME·Filed 2004·Granted Aug 31, 2010·4 cites·5 claims
- 1867US9018224B2Substituted cyclopropyl compounds useful as GPR119 agonistsMERCK SHARP & DOHME·Filed 2012·Granted Apr 28, 2015·1 cites·25 claims
- 1964US2024228535A1Protease inhibitors for treating or preventing coronavirus infectionMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2061US7166614B2Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activityMERCK SHARP & DOHME·Filed 2003·Granted Jan 23, 2007·1 cites·27 claims
- 2155US2024308980A1Heteroaryl amides as lrrk2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2255US2024018145A1Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenzaMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2354US7704988B2Anti-hypercholesterolemic compoundsMERCK & CO INC·Filed 2006·Granted Apr 27, 2010·0 cites·20 claims
- 2451US8501786B2Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonistsBERGER RICHARD·Filed 2009·Granted Aug 6, 2013·0 cites·8 claims
- 2549US2009137546A1Anti-Hypercholesterolemic CompoundsDEVITA ROBERT J·Filed 2006·Application pending·0 cites
- 2649US2008280836A1Anti-hypercholesterolemic biaryl azetidinone compoundsMORRIELLO GREGORI J·Filed 2008·Application pending·0 cites
- 2748US12319671B21-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 3, 2025·0 cites·16 claims
- 2848US2009286777A15,6,Fused Pyrrolidine Compounds Useful as Tachykinin Receptor AntagonistsBAO JIANMING·Filed 2007·Application pending·0 cites
- 2946US2010035857A1Anti-hypercholesterolemic compoundsDEVITA ROBERT J·Filed 2007·Application pending·0 cites
- 3044US2010069347A1Heterocyclyl-substituted anti-hypercholesterolemic compoundsMORRIELLO GREGORI J·Filed 2007·Application pending·0 cites
- 3143US8933102B2Pyrrolidine derived β3 adrenergic receptor agonistsMORRIELLO GREGORI J·Filed 2011·Granted Jan 13, 2015·0 cites·8 claims
- 3242US2009042854A1Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor AntagonistsBAO JIANMING·Filed 2007·Application pending·0 cites
- 3342US2010234409A1Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activityYANG LIHU·Filed 2005·Application pending·0 cites
- 3441US10647727B2Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted May 12, 2020·0 cites·12 claims
- 3541US10357481B2Substituted triazolo bicyclic compounds as PDE2 inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Jul 23, 2019·0 cites·8 claims
- 3639US2006030582A1Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activityDEMARTINO JULIE·Filed 2005·Application pending·0 cites
- 3732US8957062B2Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatmentEDMONDSON SCOTT·Filed 2012·Granted Feb 17, 2015·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Gregori J. Morriello files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →